The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer
Open accessAbstract
Prostate cancer is the most commonly diagnosed cancer disease in men in the Unites States and its management remains challenge in everyday oncology practice. Thus, advanced therapeutic strategies are required to treat prostate cancer patients. Curcumin (CUR) is a promising anticancer agent for various cancer types. The objective of this study was to evaluate therapeutic potential of novel poly(lactic-co-glycolic acid)- CUR nanoparticles (PLGA-CUR NPs) for prostate cancer treatment. Our results indicate that PLGA-CUR NPs efficiently internalize in prostate cancer cells and release biologically active CUR in cytosolic compartment of cells for effective therapeutic activity. Cell proliferation (MTS), clonogenic, and Western blot analyses reveal that PLGA-CUR NPs can effectively inhibit proliferation and colony formation ability of prostate cancer cells than free CUR. PLGA-CUR NPs showed superior tumor regression compared to CUR in xenograft mice. Further investigations reveal that PLGA-CUR NPs inhibit nuclear β-catenin and AR expression in cells and in tumor xenograft tissues. It also suppresses STAT3 and AKT phosphorylation and leads to apoptosis via inhibition of key anti-apoptotic proteins, MCL-1, Bcl-xL and caused induction of PARP cleavage. Additionally, PLGA-CUR NPs significant downregulation of oncogenic miR21 and up-regulation of miR-205 was observed with PLGA-CUR NPs treatment as determined by RT-PCR and in situ hybridization analyses. A superior anti-cancer potential was attained with PSMA antibody conjugated PLGA-CUR NPs in prostate cancer cells and a significant tumor targeting of 131I labelled PSMA antibody was achieved with PLGA-CUR NPs in prostate cancer xenograft mice model. In conclusion, PLGA-CUR NPs can significantly accumulate and exhibit superior anticancer activity in prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543 · cited 1×
“It is important to note that a trace amount of curcumin was detected in the serum of humanwhen up to 4e12 g/day of CUR was administered [12].”
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,672
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Iversen, T.-G., Skotland, T., & Sandvig, K. (2011) · Nano Today · doi:10.1016/j.nantod.2011.02.003 · Cited by 1,239
Hrkach, J., Von Hoff, D., Ali, M. M., Andrianova, E., Auer, J., Campbell, T., De Witt, D., Figa, M., Figueiredo, M., Horhota, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003651 · Cited by 1,147
Curcumin and cancer: An “old-age” disease with an “age-old” solution
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.025 · Cited by 1,132
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.009 · Cited by 1,073
Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?
Ravindran, J., Prasad, S., & Aggarwal, B. B. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9128-x · Cited by 768
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
Tomao, S. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s3061 · Cited by 695 · cited 1×
“Abraxane, a paclitaxel albumin-bound nanoparticle formulation, has been approved by the FDA and is in the market for metastasis cancer treatment(s) [18].”
Yallapu, M. M., Gupta, B. K., Jaggi, M., & Chauhan, S. C. (2010) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2010.05.022 · Cited by 579
Self-citationAoki, H., Takada, Y., Kondo, S., Sawaya, R., Aggarwal, B. B., & Kondo, Y. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033167 · Cited by 523
Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy
Yallapu, M. M., Othman, S. F., Curtis, E. T., Gupta, B. K., Jaggi, M., & Chauhan, S. C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.028 · Cited by 479
Self-citationProstate-specific membrane antigen expression as a predictor of prostate cancer progression
Perner, S., Hofer, M. D., Kim, R., Shah, R. B., Li, H., Möller, P., Hautmann, R. E., Gschwend, J. E., Kuefer, R., & Rubin, M. A. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.11.012 · Cited by 455
Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee, A., & Vishwanatha, J. K. (2009) · PubMed · Cited by 444
Gandellini, P., Folini, M., Longoni, N., Pennati, M., Binda, M., Colecchia, M., Salvioni, R., Supino, R., Moretti, R., Limonta, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2894 · Cited by 358
Advanced Drug Delivery Systems of Curcumin for Cancer Chemoprevention
Bansal, S. S., Goel, M., Aqil, F., Vadhanam, M. V., & Gupta, R. C. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0006 · Cited by 353
Burgos‐Morón, E., Calderón‐Montaño, J. M., Salvador, J., Robles, A., & López‐Lázaro, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.24967 · Cited by 336
Activation of PI3K‐Akt signaling pathway promotes prostate cancer cell invasion
Shukla, S., MacLennan, G. T., Hartman, D. J., Fu, P., Resnick, M. I., & Gupta, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22862 · Cited by 316
The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions?
Rivolta, I., Panariti, & Miserocchi (2012) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s25515 · Cited by 308
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
Epelbaum, R., Schaffer, M., Vizel, B., Badmaev, V., & Bar-Sela, G. (2010) · Nutrition and Cancer · doi:10.1080/01635581.2010.513802 · Cited by 282
Wnt/β-catenin signalling in prostate cancer
Kypta, R. M., & Waxman, J. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.116 · Cited by 275
Cancer risk and diet in India.
Sinha, R. R., Anderson, D. E., McDonald, S. S., & Greenwald, P. (2003) · PubMed · Cited by 266
Stat3 Promotes Metastatic Progression of Prostate Cancer
Abdulghani, J., Gu, L., Dagvadorj, A., Lutz, J., Leiby, B., Bonuccelli, G., Lisanti, M. P., Zellweger, T., Alanen, K., Mirtti, T., et al. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071054 · Cited by 243
Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway
Sheth, S., Jajoo, S., Kaur, T., Mukherjea, D., Sheehan, K., Rybak, L. P., & Ramkumar, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051655 · Cited by 225
Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications
Chauhan, S., Yallapu, M., Othman, S., Curtis, E., Bauer, N., Chauhan, Jaggi, & Kumar (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29290 · Cited by 221
Self-citationYallapu, M. M., Maher, D. M., Sundram, V., Bell, M. C., Jaggi, M., & Chauhan, S. C. (2010) · Journal of Ovarian Research · doi:10.1186/1757-2215-3-11 · Cited by 221
Self-citationDetection of Prostate Cancer and Predicting Progression
Tricoli, J. V., Schoenfeldt, M., & Conley, B. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0200 · Cited by 193
Crosstalk between the Androgen Receptor and β-Catenin in Castrate-Resistant Prostate Cancer
Wang, G., Wang, J., & Sadar, M. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1718 · Cited by 168
Chemopreventive potential of curcumin in prostate cancer
Teiten, M.-H., Gaascht, F., Eifes, S., Dicato, M. A., & Diederich, M. F. (2009) · Genes & Nutrition · doi:10.1007/s12263-009-0152-3 · Cited by 167
Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells
Lane, J. D., Allan, V., & Woodman, P. G. (2005) · Journal of Cell Science · doi:10.1242/jcs.02529 · Cited by 145
Mechanisms of action of novel agents for prostate cancer chemoprevention
Singh, R. P., & Agarwal, R. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01126 · Cited by 141
Thomas, T. P., Majoros, I., Kotlyar, A., Mullen, D. G., Holl, M. M. B., & Baker, J. R. (2009) · Biomacromolecules · doi:10.1021/bm900683r · Cited by 134
Design of Curcumin loaded Cellulose Nanoparticles for Prostate Cancer
Yallapu, M. M., Dobberpuhl, M. R., Maher, D. M., Jaggi, M., & Chauhan, S. C. (2011) · Current Drug Metabolism · doi:10.2174/138920012798356952 · Cited by 129
Self-citationComplex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells
Yang, X., Chen, M.-W., Terry, S., Vacherot, F., Bemis, D. L., Capodice, J. L., Kitajewski, J., TAILLE, A. D. L., Benson, M. C., Guo, Y., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209366 · Cited by 123
Expression and Functions of Transmembrane Mucin MUC13 in Ovarian Cancer
Chauhan, S. C., Vannatta, K., Ebeling, M. C., Vinayek, N., Watanabe, A., Pandey, K. K., Bell, M. C., Koch, M. D., Aburatani, H., Lio, Y., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0587 · Cited by 120
Self-citationPolyphenols: Key Issues Involved in Chemoprevention of Prostate Cancer
Cimino, S., Sortino, G., Favilla, V., Castelli, T., Madonia, M., Sansalone, S., Russo, G. I., & Morgia, G. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/632959 · Cited by 119
Chemoprevention strategies for pancreatic cancer
Stan, S. D., Singh, S. V., & Brand, R. E. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.61 · Cited by 118
Sundram, V., Chauhan, S. C., Ebeling, M. C., & Jaggi, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035368 · Cited by 98
Self-citationInteraction of curcumin nanoformulations with human plasma proteins and erythrocytes
Chauhan, S. C., Yallapu, M. M., Ebeling, Chauhan, & Jaggi (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s25534 · Cited by 96
Self-citationTahara, Y., Nakamura, M., Yang, M., Zhang, M., Iijima, S., & Yudasaka, M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.023 · Cited by 78
Desmoplasia in Pancreatic Cancer. Can We Fight It?
Merika, E., Syrigos, K. N., & Saif, M. W. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/781765 · Cited by 71
Caspases : their role in cell death and cell survival
Łos, M. J., & Walczak, H. (2002) · Medical Entomology and Zoology · Cited by 65
Snyder, C. F., Frick, K. D., Blackford, A. L., Herbert, R. J., Neville, B. A., Carducci, M. A., & Earle, C. C. (2010) · Cancer · doi:10.1002/cncr.25517 · Cited by 59
Interaction of β-Catenin and TIF2/GRIP1 in Transcriptional Activation by the Androgen Receptor
Song, L., & Gelmann, E. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503850200 · Cited by 52
Mo, L., Hou, L., Guo, D., Xiao, X., Mao, P., & Yang, X. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.050 · Cited by 51
Ungaro, F., Conte, C., Ostacolo, L., Maglio, G., Barbieri, A., Arra, C., Misso, G., Abbruzzese, A., Caraglia, M., & Quaglia, F. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.08.012 · Cited by 45
Jaggi, M., Chauhan, S. C., Du, C., & Balaji, K. C. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0119 · Cited by 37
Self-citationKhan, S., Chib, R., Shah, B. A., Wani, Z. A., Dhar, N., Mondhe, D. M., Lattoo, S. K., Jain, S. K., Taneja, S. C., & Singh, J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.013 · Cited by 35
Self-citationGianino, M. M., Galzerano, M., Minniti, D., Novi, C. D., Martin, B. S., Davini, O., & Barbaro, S. (2009) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462309990043 · Cited by 13
Cited by
Therapeutic Applications of Curcumin Nanoformulations
Yallapu, M. M., Nagesh, P. K. B., Jaggi, M., & Chauhan, S. C. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9811-z · Cited by 392
Self-citationAbd El‐Hack, M. E., El‐Saadony, M. T., Swelum, A. A., Arif, M., Abo Ghanima, M. M., Shukry, M., Noreldin, A., Taha, A. E., & El‐Tarabily, K. A. (2021) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.11372 · Cited by 392
Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents
Hashem, S., Ali, T. A., Akhtar, S., Nisar, S., Sageena, G., Ali, S., Al-Mannai, S., Therachiyil, L., Mir, R., Elfaki, I., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113054 · Cited by 377
Curcumin mediates anticancer effects by modulating multiple cell signaling pathways
Kunnumakkara, A. B., Bordoloi, D., Harsha, C., Banik, K., Gupta, S. C., & Aggarwal, B. B. (2017) · Clinical Science · doi:10.1042/cs20160935 · Cited by 332
miRNA nanotherapeutics for cancer
Ganju, A., Khan, S., Hafeez, B. B., Behrman, S. W., Yallapu, M. M., Chauhan, S. C., & Jaggi, M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.10.014 · Cited by 298
Self-citation
Metadata
- Authors
- Yallapu, M. M., Khan, S., Maher, D. M., Ebeling, M. C., Sundram, V., Chauhan, N., Ganju, A., Balakrishna, S., Gupta, B. K., Zafar, N., Jaggi, M., & Chauhan, S. C.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 35
- Issue
- 30
- Pages
- 8635-8648
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W1988943017
- Cited by
- 290
- References
- 51
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.